This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Capranico, G. Articles by Zunino, F. Search for Related Content PubMed PubMed Citation Articles by Capranico, G. Articles by Zunino, F.

Role of DNA Breakage in Cytotoxicity of Doxorubicin, 9-Deoxydoxorubicin, and 4-Demethyl-6-deoxydoxorubicin in Murine Leukemia P388 Cells¹

Division of Experimental Oncology B, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via G. Venezian 1, 20133 Milan, Italy [G. C., P. D., S. T., F. Z.], and Farmitalia-Carlo Erba, Via dei Gracchi 35, 20144 Milan, Italy [S. P.]

Formation and persistence of DNA single- and double-strand breaks stimulated by doxorubicin, 9-deoxydoxorubicin, or 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells were compared in relation to drug DNA affinity, cellular pharmacokinetics, and cytotoxicity. Although cellular uptake and retention and DNA affinity of the anthracycline derivatives were similar to those of the parent drug, cytotoxic potency was quite different, 9-deoxydoxorubicin being much less cytotoxic than doxorubicin, and 4-demethyl-6-deoxydoxorubicin the most effective agent. After 1-h exposure of cells to cytotoxic drug levels, the extent of DNA strand breaks produced by 4-demethyl-6-deoxydoxorubicin was greater than that produced by doxorubicin, whereas 9-deoxydoxorubicin induced very few DNA breaks. As for the parent drug, proteolytic treatment of cell lysates on the filter was needed to detect DNA cleavage produced by the analogues. A linear increase of DNA breaks was observed for 2 h following 4-demethyl-6-deoxydoxorubicin or doxorubicin addition; by contrast, DNA break levels reached a plateau after 45 min of exposure to 9-deoxydoxorubicin. DNA lesions produced by the derivatives persisted, and doxorubicin-induced DNA breaks even increased after drug removal, indicating an absence of DNA break resealing under our conditions. These observations indicate that modifications of the chromophore moiety of the anthracycline may enhance both drug cytotoxicity and specificity of drug-target interactions, and thus provide further strong evidence that the anthracycline effect on DNA integrity is a critical aspect of the mechanism of drug action.

¹ This work was supported in part by Consiglio Nazionale delle Ricerche (Target Project "Oncologia") and in part by a grant from the Italian Ministero della Sanitá.

² To whom requests for reprints should be addressed.

Received 5/12/88. Revised 1/ 3/89. Accepted 1/12/89.

This article has been cited by other articles:

				A. Lynch, J. Harvey, M. Aylott, E. Nicholas, M. Burman, A. Siddiqui, S. Walker, and R. Rees Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity Mutagenesis, July 1, 2003; 18(4): 345 - 353. [Abstract] [Full Text] [PDF]

				M. Binaschi, G. Capranico, L. Dal Bo, and F. Zunino Relationship between Lethal Effects and Topoisomerase II-Mediated Double-Stranded DNA Breaks Produced by Anthracyclines with Different Sequence Specificity Mol. Pharmacol., June 1, 1997; 51(6): 1053 - 1059. [Abstract] [Full Text]